|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
208,280,000 |
Market
Cap: |
1.95(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$5.09 - $15.86 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,693,990 |
Total Buy Value |
$0 |
$0 |
$0 |
$12,897,789 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
27 |
Total Shares Sold |
567,946 |
1,097,598 |
2,193,115 |
3,020,700 |
Total Sell Value |
$5,420,056 |
$10,572,222 |
$21,602,157 |
$28,825,014 |
Total People Sold |
4 |
7 |
8 |
8 |
Total Sell Transactions |
23 |
46 |
97 |
149 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Virani Shafique |
Chief Business Officer |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
117,090 |
192,840 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-01 |
4 |
B |
$7.97 |
$4,782 |
I/I |
600 |
12,354,744 |
1.42 |
15% |
|
Larson Tina Marriott |
President and COO |
|
2023-01-26 |
4 |
AS |
$8.07 |
$64,547 |
D/D |
(8,000) |
203,654 |
|
5% |
|
Larson Tina Marriott |
President and COO |
|
2023-01-26 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
211,654 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-26 |
4 |
B |
$7.99 |
$63,006 |
I/I |
7,886 |
12,354,144 |
1.5 |
5% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-25 |
4 |
B |
$7.88 |
$193,267 |
I/I |
24,526 |
12,346,258 |
1.5 |
3% |
|
Borgeson Blake |
Director |
|
2023-01-24 |
4 |
AS |
$8.71 |
$77,368 |
D/D |
(8,885) |
7,611,827 |
|
-4% |
|
Virani Shafique |
Chief Business Officer |
|
2023-01-17 |
4 |
AS |
$9.16 |
$91,561 |
D/D |
(10,000) |
73,160 |
|
-6% |
|
Virani Shafique |
Chief Business Officer |
|
2023-01-17 |
4 |
OE |
$2.22 |
$11,100 |
D/D |
5,000 |
83,160 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-10 |
4 |
B |
$7.72 |
$536,846 |
I/I |
69,518 |
12,321,732 |
1.5 |
-17% |
|
Borgeson Blake |
Director |
|
2023-01-10 |
4 |
AS |
$7.69 |
$68,283 |
D/D |
(8,885) |
7,620,712 |
|
-17% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-09 |
4 |
B |
$7.64 |
$580,839 |
I/I |
76,046 |
12,252,214 |
1.5 |
-27% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-06 |
4 |
B |
$7.41 |
$510,611 |
I/I |
68,953 |
12,176,168 |
1.5 |
-28% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
963,710 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
966,710 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-05 |
4 |
B |
$7.38 |
$590,554 |
I/I |
80,035 |
12,107,215 |
1.5 |
-30% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-04 |
4 |
B |
$7.80 |
$716,877 |
I/I |
91,892 |
12,027,180 |
1.5 |
-28% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-01-03 |
4 |
B |
$7.50 |
$1,063,011 |
I/I |
141,646 |
11,935,288 |
1.5 |
-30% |
|
Bogue Zachary |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,407 |
6,396 |
|
- |
|
Burrell Terry-Ann |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,821 |
159,235 |
|
- |
|
Chavez R Martin Phd |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,483 |
35,684 |
|
- |
|
Li Dean Y |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,573 |
621,685 |
|
- |
|
Borgeson Blake |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,325 |
7,629,597 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2022-12-30 |
4 |
B |
$7.55 |
$753,622 |
I/I |
99,754 |
11,793,642 |
1.5 |
-30% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2022-12-29 |
4 |
B |
$7.71 |
$652,774 |
I/I |
84,622 |
11,693,888 |
1.5 |
-28% |
|
628 Records found
|
|
Page 13 of 26 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|